No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Elastomeric Infusion Pumps Market Report 2022: Rising Preference for Long-Term Home Healthcare Drives Growth

Editor: What To Know

  • Higher affordability, greater awareness in hospital staff, and potential of elastomeric infusion pump in reducing manpower and treatment costs in the long run greatly contribute to the dominance of hospitals and clinics in the market.
  • Ambulatory Care Segment is Expected to Exhibit Exponential GrowthThe ambulatory care segment is expected to exhibit exponential growth in the usage area segment, while hospitals held the largest share in the elastomeric infusion pumps market due to better reimbursement scenarios and cost structure.
  • Variable Rate Infusion Pumps are expected to show the fastest growthFor the purpose of this study, the global elastomeric infusion pumps market is studied for various segments based on product types, treatment types, usage areas, and geographical distribution.

The “Elastomeric Infusion Pumps Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030″ report has been added to ResearchAndMarkets.com’s offering.

Elastomeric Infusion Pumps Market is Expected to Grow at 7.0% from 2022-2030.

Elastomeric infusion pumps are disposable medical used for the administration of liquid drugs such as analgesics, antibiotics, chemotherapy medications, etc.

The rise in the adoption of elastomeric pumps is attributed to driving factors such as growth in demand for disposable ambulatory pumps, rising preference for long-term home healthcare, growing hospitalization rates, and evolving reimbursement policies.

Variable Rate Infusion Pumps are expected to show the fastest growth

For the purpose of this study, the global elastomeric infusion pumps market is studied for various segments based on product types, treatment types, usage areas, and geographical distribution. The continuous rate pumps held the largest market, while the variable rate infusion pumps are expected to bolster the fastest growth during the forecast period due to product innovation. In terms of treatment type, the pain management segment held the largest market due to the increasing usage of elastomeric infusion pumps for port operative pain management.

Elastomeric infusion pumps have applications for pain management, infection management, cytostatic treatment, chelation therapy. Major application of infusion pump is for postoperative analgesia for pain management. Thus, pain management occupies the largest share of in application segment of elastomeric infusion market. It is followed by cytostatic treatment since infusion pump therapy proves more effective and well-tolerated in patient.

Ambulatory Care Segment is Expected to Exhibit Exponential Growth

The ambulatory care segment is expected to exhibit exponential growth in the usage area segment, while hospitals held the largest share in the elastomeric infusion pumps market due to better reimbursement scenarios and cost structure. In terms of geography, North America dominated the global elastomeric infusion pumps market due to greater acceptance of elastomeric infusion pumps, developed healthcare infrastructure, and well organized reimbursement scenarios. Asia Pacific is expected to grow at the fastest rate during the forecast period to increasing investment and market entry of manufacturers in the region.

Among the considered usage areas, hospitals and clinics currently dominate the global elastomeric infusion pumps market. Higher affordability, greater awareness in hospital staff, and potential of elastomeric infusion pump in reducing manpower and treatment costs in the long run greatly contribute to the dominance of hospitals and clinics in the market. Furthermore, better reimbursement policies and growing preference for home care in order to save treatment costs have led to rapid market growth of home care segment during the forecast period.

Asia Pacific Dominates the Market

In the base 2020, North America was observed as the largest market for elastomeric infusion pumps followed by Europe. In North America and Europe there is an increase in the chronic diseases like gastrointestinal complications, abdominal hernia’s, etc. Asia-Pacific and Middle East and Africa are potential market due to the high prevalence of chronic diseases requiring surgical procedure but less disease awareness.

Prominent Key Players

  • Baxter International, Inc.
  • B. Braun Melsungen
  • PFM Medical
  • Gamastech SRL
  • Halyard Health, Inc.
  • Nipro Corporation
  • Woo Young Medical Co.


Market Segmentation
Type

  • Continuous Rate Pumps
  • Variable rate pumps

Treatment

  • Pain Management(Anesthetics and Analgesics)
  • Infection Management (Antibiotics/antivirals)
  • Cytostatic Treatment
  • Others (Chelation, etc)

Usage Area

  • Hospitals and Clinics
  • Ambulatory Care
  • Home Care

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Elastomeric Infusion Pumps market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Elastomeric Infusion Pumps market?
  • Which is the largest regional market for Elastomeric Infusion Pumps market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Elastomeric Infusion Pumps market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Elastomeric Infusion Pumps market worldwide?

Key Topics Covered:

1. Preface

2. Executive Summary

3. Elastomeric Infusion Pumps Market: Competitive Analysis

4. Elastomeric Infusion Pumps Market: Macro Analysis & Market Dynamics

5. Elastomeric Infusion Pumps Market: By Type, 2020-2030, USD (Million)

6. Elastomeric Infusion Pumps Market: By Treatment, 2020-2030, USD (Million)

7. Elastomeric Infusion Pumps Market: By Usage Area, 2020-2030, USD (Million)

8. North America Elastomeric Infusion Pumps Market, 2020-2030, USD (Million)

9. UK and European Union Elastomeric Infusion Pumps Market, 2020-2030, USD (Million)

10. Asia Pacific Elastomeric Infusion Pumps Market, 2020-2030, USD (Million)

11. Latin America Elastomeric Infusion Pumps Market, 2020-2030, USD (Million)

12. Middle East and Africa Elastomeric Infusion Pumps Market, 2020-2030, USD (Million)

13. Company Profile

Companies Mentioned

  • Baxter International Inc.
  • B. Braun Melsungen
  • PFM Medical
  • Gamastech SRL
  • Halyard Health Inc.
  • Nipro Corporation
  • Woo Young Medical Co.

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy